Cargando…
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients
High-Grade Serous Ovarian Carcinoma (HGSOC) is the predominant histotype of epithelial ovarian cancer (EOC), characterized by advanced stage at diagnosis, frequent TP53 mutation, rapid progression, and high responsiveness to platinum-based-chemotherapy. To date, standard first-line-chemotherapy in a...
Autores principales: | Mignogna, Chiara, Staropoli, Nicoletta, Botta, Cirino, De Marco, Carmela, Rizzuto, Antonia, Morelli, Michele, Di Cello, Annalisa, Franco, Renato, Camastra, Caterina, Presta, Ivan, Malara, Natalia, Salvino, Angela, Tassone, Pierfrancesco, Tagliaferri, Pierosandro, Barni, Tullio, Donato, Giuseppe, Di Vito, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875597/ https://www.ncbi.nlm.nih.gov/pubmed/27209210 http://dx.doi.org/10.1186/s13048-016-0238-7 |
Ejemplares similares
-
A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
por: Staropoli, Nicoletta, et al.
Publicado: (2013) -
Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigation
por: Staropoli, Nicoletta, et al.
Publicado: (2016) -
Myeloid-Derived Suppressor Cells in Multiple Myeloma: Pre-Clinical Research and Translational Opportunities
por: Botta, Cirino, et al.
Publicado: (2014) -
Mouse models of multiple myeloma: technologic platforms and perspectives
por: Rossi, Marco, et al.
Publicado: (2018) -
Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates
por: Gallo Cantafio, Maria Eugenia, et al.
Publicado: (2016)